Navigation Links
Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
Date:5/15/2008

a experienced a 20 percent tumor reduction. Lastly, a patient with NK/T cell lymphoma had a 75 percent reduction in tumor measurements. Adverse events included two Grade 3 dose- limiting toxicities (upper respiratory infection (URI) and elevated liver enzymes) and five cases of Grade 3 thrombocytopenia (low-platelet count) without any sign of bleeding.

Reductions in platelet counts were analyzed in the three ongoing Phase I trials as a biomarker of Bcl-2 family protein inhibition. Subjects received doses ranging from 10 mg to 315 mg. The study data demonstrate that ABT-263 induces a transient decrease in circulating platelets via inhibition of Bcl- XL, without decreasing platelet production, confirming on-target activity. At 315 mg, researchers observed a 69 percent reduction in mean platelets from baseline values. Typically, platelet nadir occurred on days three to five with recovery during continued dosing. Tumor regression was observed in six patients, with three patients showing more than 50 percent tumor shrinkage. Adverse events included three dose-limiting toxicities, one Grade 3 URI at 160 mg, one Grade 3 alanine aminotransferase (ALT) elevation at 315 mg and one fatal respiratory failure at 10 mg. Updated information will be presented at the ASCO Annual Meeting.

ABT-869

Twenty-four patients from a completed Phase I trial (ABT-869), which studied three dose levels of ABT-869, were evaluated to compare two different measures of angiogenesis using functional imaging -- the distributed parameter (DP) model and the transfer constant (Ktrans) model. DP is a dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) model that enables derivation of blood flow and capillary permeability-surface area product (PS). Tests indicated that time over threshold could be an important predictor of efficacy, and results demonstrated that an appropriate value for the plasma concentration threshold could be 0.08 ug/mL, with time above threshold value of
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Abbott to Present at Citi Investment Research Global Health Care Conference
2. Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
3. Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
4. Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
5. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
6. Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
7. Abbott Hosts Conference Call for First-Quarter Earnings
8. Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
9. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
10. Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
11. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 27, 2015 Women may have a ... according to a new study published online in the ... brain injury (MTBI), is a common medical problem affecting ... , In most cases, patients who experience MTBI ... 15 percent of MTBI patients will continue to experience ...
(Date:4/27/2015)... Moreno Ranches, a producer of Brahman ... to announce their "This is It" educational Brahman cattle ... breeding and education was a huge success. The educational ... 2015. It brought together youth, educators, and experts ... breeding in general, and Brahman cattle breeding in particular. ...
(Date:4/27/2015)... April 27, 2015 UC Davis ... molecular basis of an inherited disorder that historically ... also arises in other populations of Semitic descent, ... series of elegant experiments, the researchers uncovered the ... leukodystrophy that is an incurable and progressively fatal ...
(Date:4/27/2015)... April 27, 2015 On May 5, people ... ask their social media friends around the world to join ... asthma. , May 5 is World Pulmonary Hypertension Day ... leader in the global PH community, will take part in ... blood pressure of the lungs. PH is an increase in ...
(Date:4/27/2015)... Array Health , a leading provider ... Lance Hood, senior director of marketing, will participate in ... Health Care Marketing Summit on April 29, 2015. ... Director of Payer Services, Leavitt Partners, LLC, will address ... a retail/e-commerce perspective – and equip attendees with the ...
Breaking Medicine News(10 mins):Health News:Women Show Persistent Memory Impairment after Concussion 2Health News:Women Show Persistent Memory Impairment after Concussion 3Health News:Leading Ranch for Brahman Cattle for Sale, Moreno Ranches, Announces Conclusion of 'This is It' Event for Brahman Juniors. 2Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 2Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 3Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 4Health News:Pulmonary Hypertension Association Marks World PH Day on May 5 with a Worldwide Lifesaving Social Media Blitz 2Health News:Pulmonary Hypertension Association Marks World PH Day on May 5 with a Worldwide Lifesaving Social Media Blitz 3Health News:Array Health’s Senior Director of Marketing to Present at The Fourth Annual Direct-to-Consumer Health Care Marketing Summit 2
... life when some students pushed him from the front bench in ... ,Qamar Irfan, a Class 5 student of Sarda Convent School in ... forcibly pushed off the bench by students in a fight over ... members, Qamar rushed into the class as soon as school opened ...
... diagnosed with stomach cancer. He was 68 years old then.// ... out that the hospital pathologist had misdiagnosed tests and Mr. ... out in October 2002 at Walsall Manor Hospital. The pathologist ... Wolverhampton trust. Royal Wolverhampton Hospitals NHS Trust owned up liability ...
... who are circumcised are less likely to contract HIV ... research presented recently at the International AIDS Conference at ... percent less likely to contract HIV than their uncircumcised ... ,Circumcision is the surgical removal of the foreskin ...
... New York shows that patients, who experience the health ... //be a lot done for its improvement, with almost ... health care. ,According to the ... Performance Health System, an astonishingly high amount of Americans, ...
... According to a new study by Duke University Medical ... the rate of treatment //for chronic hepatitis C than ... in the August issue of Gastroenterology, which is the ... (AGA), that the African American patients with hepatitis C ...
... The Health Service Executive in Ireland is all set to ... emergency overcrowding.// ,The Irish Examiner reports that hospitals may ... with the A&E crisis, where patients are made to wait ... A&E patients are not made to wait over 24 hours. ...
Cached Medicine News:Health News:Majority Of People In US Seek Essential Changes In Health Care System 2Health News:Majority Of People In US Seek Essential Changes In Health Care System 3Health News:Majority Of People In US Seek Essential Changes In Health Care System 4Health News:African-Americans Have A Reduced Response To Hepatitis C Treatment 2Health News:African-Americans Have A Reduced Response To Hepatitis C Treatment 3
(Date:4/27/2015)... April 27, 2015  Eiger BioPharmaceuticals, Incorporated today announced ... of lonafarnib in patients with chronic hepatitis delta viral ... program, enrolled at Ankara University Medical School, ... endemic. LOWR HDV - 1 (LOnafarnib ... study which randomized subjects to receive different doses of ...
(Date:4/27/2015)... 27, 2015 Kalorama Information expects the ... (EMR) to grow well past the period where ... to a recent report.  The healthcare market research ... continued efficiency improvements will grow the market seven ... five years.  The market for EMR systems continues ...
(Date:4/27/2015)... 2015  Novira Therapeutics, Inc., a privately held, clinical-stage ... chronic hepatitis B virus (HBV) infection, today announced the ... core inhibitor candidate, NVR 3-778, at the 2015 annual ... the Liver (EASL) in Vienna, Austria ... from studies performed in a humanized UPA/SCID mouse model ...
Breaking Medicine Technology:Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 3Kalorama: EMR Market Expected To Grow Beyond Incentives 2Kalorama: EMR Market Expected To Grow Beyond Incentives 3Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL 2Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL 3
... 17, 2011 Damage to the spine can happen for ... car accident, wear and tear from old age, or blunt ... past have had to deal with back braces, reduced mobility, ... Seyed M. Rezaian,s patented Spinal Fixator, patients are able to ...
... Unilife Corporation ("Unilife" or the "Company") (NASDAQ: ... Deputy Secretary of the U.S. Department of Agriculture, for a ... at its facility in York, Pennsylvania. The White ... direction of President Obama. The Winning the Future Roundtables ...
Cached Medicine Technology:Dr. Seyed M. Rezaian's Spinal Fixator a Revolutionary Invention for Healing Injuries of the Thoracolumbar Spine 2Unilife Hosts White House Business Council Meeting 2Unilife Hosts White House Business Council Meeting 3
IFA for the direct detection of Respiratory Syncytial Virus (RSV)...
... RSV Test utilizes a new, improved format that ... rapid RSV detection. The testing device employs innovative ... reagents have already been applied to the testing ... with clear-cut results shown by the appearance of ...
Latex agglutination slide test for the qualitative detection of rotavirus from fecal specimens....
ELISA for Anti-Proteinase 3 PR3 (cANCA)....
Medicine Products: